Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck. - Baselga,J.; Trigo,J.M.; Bourhis,J.; Tortochaux,J.; Cortes-Funes,H.; Hitt,R.; Gascon,P.; Amellal,N.; Harstrick,A.; Eckardt,A. (J Clin Oncol, 2005)